Revenue
2018
2019
2020
2021
2022
2023
2024
2025
American Healthcare REIT, Inc. (AHR)
Price—Loading quote
Net income
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2018
2019
2020
Total cash / debt
CashTotal debt
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.09B | $1.88B | $1.67B | $1.41B | $1.12B | $1.07B | $1.10B | $36.9M | $5.6M | $0 | $0 |
| Operating expenses | — | — | — | — | — | — | — | — | — | $437,000 | — |
| Operating income | $415.2M | $363.5M | $306.8M | $302.0M | $213.3M | $218.3M | $221.4M | — | — | −$5.0M | $0 |
| EBITDAderived | $602.7M | $542.7M | $489.4M | $469.9M | $346.5M | $317.1M | $332.8M | — | — | −$3.7M | $0 |
| Net income | $69.8M | −$37.8M | −$71.5M | −$81.3M | −$47.8M | $2.2M | −$5.0M | −$8.4M | $541,000 | −$5.5M | $0 |
| Basic EPSper diluted share | $0.42 | -$0.29 | -$1.08 | -$1.24 | -$0.95 | $0.05 | -$0.03 | -$0.15 | $0.02 | -$1.75 | $0.00 |
| Diluted EPSper diluted share | $0.42 | -$0.29 | -$1.08 | -$1.24 | -$0.95 | $0.05 | -$0.03 | -$0.15 | $0.02 | -$1.75 | $0.00 |
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 26, 2026Form 4 | PEAY BRIANChief Financial Officer | SellCommon Stock | 25.0K | $50.70 | $1.27M | 152.7K |
| Jun 24, 2026Form 4 | Foster Mark E.EVP, GC & Secretary | SellCommon Stock | 2.5K | $48.58 | $121.5K | 53.0K |
| Jun 1, 2026Form 4 · 10b5-1 | Foster Mark E.EVP, GC & Secretary | SellCommon Stock | 2.0K | $48.32 | $96.6K | 55.5K |
| Mar 25, 2026Form 4 · 10b5-1 | Foster Mark E.EVP, GC & Secretary | SellCommon Stock | 2.0K | $48.55 | $97.1K | 56.1K |
| Dec 23, 2025Form 4 | Hanson Jeffrey TDirector | SellCommon Stock · indirect | 19.2K | $48.40 | $929.7K | 0 |